目的：对比分析美托洛尔与地尔硫卓治疗反复心肌梗塞的效果。方法抽取我院2011年2月～2015年2月收治的68例反复心肌梗死患者为研究对象，根据不同用药方案分为美托洛尔组（使用美托洛尔治疗）和地尔硫卓组（使用地尔硫卓治疗），每组34例。对比两组出现心衰率、疼痛再发率以及疼痛缓解率。结果美托洛尔组的出现心衰率、疼痛再发率分别为23.53%、17.65%，地尔硫卓则分别为88.24%、58.82%，美托洛尔组出现心衰率与疼痛再发率均比地尔硫卓组低，均P＜0.05，差异具有统计学意义；美托洛尔组疼痛缓解率为67.65%，地尔硫卓组为20.59%，美托洛尔组疼痛缓解率更高，差异具有统计学意义，P＜0.05。结论与地尔硫卓相比，使用美托洛尔治疗反复心肌梗塞效果更好。%Objective Comparison of the efficacy of metoprolol and diltiazem in recurrent myocardial infarction. Methods 68 cases of recurrent myocardial infarction patients were choose for the study from February 2011 to February 2015, depending on the drug program was divided into metoprolol (metoprolol treatment) and to diltiazem group (use to diltiazem treatment), 34 cases each. Compared two groups of heart failure rate, recurrence rate of pain and pain relief. Results Heart failure rate and pain recurrence rate metoprolol group was 23.53% and 17.65%, respectively, diltiazem respectively 88.24% and 58.82%, Metoprolol group of heart failure occurs with pain recurrence rate ratios were lower than diltiazem, all P<0.05, the results were statistically signiifcant, metoprolol group pain relief was 67.65%, to diltiazem group 20.59%, metoprolol higher pain relief, with statistical significance, P<0.05. Conclusion Compared with diltiazem, the effect of metoprolol in treatment of recurrent myocardial infarction more apparent.
展开▼
